Aspirin Dose and Prevention of Coronary Abnormalities in Kawasaki Disease.

MLA

Dallaire, Frederic, et al. “Aspirin Dose and Prevention of Coronary Abnormalities in Kawasaki Disease.” Pediatrics, vol. 139, no. 6, June 2017. EBSCOhost, https://doi.org/10.1542/peds.2017-0098.

APA

Dallaire, F., Fortier-Morissette, Z., Blais, S., Dhanrajani, A., Basodan, D., Renaud, C., Mathew, M., De Souza, A. M., Dionne, A., Blanchard, J., Saulnier, H., Kaspy, K., Rached-d’Astous, S., Dahdah, N., McCrindle, B. W., Human, D. G., & Scuccimarri, R. (2017). Aspirin Dose and Prevention of Coronary Abnormalities in Kawasaki Disease. Pediatrics, 139(6). https://doi.org/10.1542/peds.2017-0098

Chicago

Dallaire, Frederic, Zoe Fortier-Morissette, Samuel Blais, Anita Dhanrajani, Dania Basodan, Claudia Renaud, Mathew Mathew, et al. 2017. “Aspirin Dose and Prevention of Coronary Abnormalities in Kawasaki Disease.” Pediatrics 139 (6). doi:10.1542/peds.2017-0098.